Generation and characterization of novel human IRAS monoclonal antibodies

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Li, Jin ^a   Wang, Bo ^a   Liu, Ying ^a   Shan, Yajun ^b   Yao, Zhenyu ^b   Liu, Xiaolan ^b   Su, Ruibin ^a   Sun, Qihong ^b   Cong, Yuwen ^b  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; HYBRID PROTEIN; IMIDAZOLINE RECEPTOR; IMIDAZOLINE RECEPTOR ANTISERA SELECTED PROTEIN; IRAS MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MORPHINE; NUSA IRAS FUSION PROTEIN; UNCLASSIFIED DRUG; NISCH PROTEIN, HUMAN; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPLASM; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDOMA; HYBRIDOMA CELL CULTURE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPIATE ADDICTION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; ESCHERICHIA COLI; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS;

MUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; IMIDAZOLINE RECEPTORS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS;

EID: 69249222648     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/973754     Document Type: Article

References (31)

1. Bousquet P., Feldman J., Schwartz J., Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines Journal of Pharmacology and Experimental Therapeutics 1984 230 1 232 236
2. Ernsberger P., Graves M. E., Graff L. M., I1-imidazoline receptors: definition, characterization, distribution, and transmembrane signaling Annals of the New York Academy of Sciences 1995 763 22 42
3. Tesson F., Parini A., Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex European Journal of Pharmacology 1991 208 1 81 83
4. Chan S. L. F., Brown C. A., Scarpello K. E., Morgan N. G., The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites British Journal of Pharmacology 1994 112 4 1065 1070
5. Molderings G. J., Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnosis Drugs of the Future 1997 22 7 757 772
6. Ernsberger P., Damon T. H., Graff L. M., Schfer S. G., Christen M. O., Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites Journal of Pharmacology and Experimental Therapeutics 1993 264 1 172 182
7. Tesson F., Limon-Boulez I., Urban P., Localization of I2-imidazoline binding sites on monoamine oxidases Journal of Biological Chemistry 1995 270 17 9856 9861
8. Raddatz R., Parini A., Lanier S. M., Localization of the imidazoline binding domain on monoamine oxidase B Molecular Pharmacology 1997 52 4 549 553
9. Morgan N. G., Chan S. L. F., Brown C. A., Tsoli E., Characterization of the imidazoline binding site involved in regulation of insulin secretion Annals of the New York Academy of Sciences 1995 763 361 373
10. Raddatz R., Parini A., Lanier S. M., Imidazoline/guanidinium binding domains on monoamine oxidases: relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B Journal of Biological Chemistry 1995 270 46 27961 27968
11. Piletz J. E., Andorn A. C., Unnerstall J. R., Halaris A., Binding of [3H]-p-aminoclonidine to 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes Biochemical Pharmacology 1991 42 3 569 584
12. Ernsberger P., Shen I.-H., Membrane localization and guanine nucleotide sensitivity of medullary I1-imidazoline binding sites Neurochemistry International 1997 30 1 17 23
13. Heemskerk F. M. J., Dontenwill M., Greney H., Vonthron C., Bousquet P., Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem Journal of Neurochemistry 1998 71 5 2193 2202
14. Piletz J. E., Ivanov T. R., Sharp J. D., Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization DNA and Cell Biology 2000 19 6 319 329
15. Dontenwill M., Pascal G., Piletz J. E., IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells Cell Death and Differentiation 2003 10 8 933 935
16. Dontenwill M., Piletz J. E., Chen M., IRAS is an anti-apoptotic protein Annals of the New York Academy of Sciences 2003 1009 400 412
17. Dupuy L., Urosevic D., Greney H., I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells Cell Death and Differentiation 2004 11 9 1049 1052
18. Piletz J. E., Wang G., Zhu H., Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue Annals of the New York Academy of Sciences 2003 1009 392 399
19. Alahari S. K., Lee J. W., Juliano R. L., Nischarin, a novel protein that interacts with the integrin 5 subunit and inhibits cell migration Journal of Cell Biology 2000 151 6 1141 1154
20. Sun Z., Chang C. H., Ernsberger P., Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells Journal of Neurochemistry 2007 101 99 108
21. Molderings G. J., Bnisch H., Brss M., Wolf C., von Kgelgen I., Gthert M., S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I1 receptor ligands Neurochemistry International 2007 51 8 476 485
22. Wu N., Su R.-B., Xu B., IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence Biochemical Pharmacology 2005 70 7 1079 1087
23. Zhu H., Hayes J., Chen M., Baldwin J., Piletz J. E., Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS Annals of the New York Academy of Sciences 2003 1009 439 446
24. Ponting C. P., Novel domains in NADPH oxidase subunits, sorting nexins, and PtdIns 3- kinases: binding partners of SH3 domains? Protein Science 1996 5 11 2353 2357
25. Nelson P. N., Reynolds G. M., Waldron E. E., Ward E., Giannopoulos K., Murray P. G., Monoclonal antibodies Molecular Pathology 2000 53 3 111 117
26. Yuan X., Cong Y., Hao J., Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor Journal of Molecular Biology 2004 339 1 131 144
27. Yuan X., Li J., Shan Y., Subcellular localization and membrane association of SARS-CoV 3a protein Virus Research 2005 109 2 191 202
28. Deng L.-W., Chiu I., Strominger J. L., MLL5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression Proceedings of the National Academy of Sciences of the United States of America 2004 101 3 757 762
29. Harrison R. G., Expression of soluble heterologous proteins via fusion with NusA protein Innovations 2000 11 4 7
30. Lim K.-P., Hong W., Human nischarin/imidazoline receptor antisera-selected protein is targeted to the endosomes by a combined action of a PX domain and a coiled-coil region Journal of Biological Chemistry 2004 279 52 54770 54782
31. Zheng B., Ma Y. C., Ostrom R. S., RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking Science 2001 294 1845 1847